Clinical Trial Update: Observational Study of NovoNorm® in Subjects With Diabetes

View source ↗

Summary

An update on a completed observational study evaluating NovoNorm (repaglinide) in subjects with diabetes, including type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoNorm (repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED